Navigation Links
Researchers & Department of Defense Question Multiple Vaccine Administration

SafeMinds Asks, "Is Mercury a Common Factor?"

WASHINGTON, Dec. 4 /PRNewswire-USNewswire/ -- Two new reports announced last week call into question the safety of the Centers for Disease Control (CDC) decade's old policy of routinely administering multiple vaccines concurrently.

Mitochondrial Disease in Autism Spectrum Disorder Patients, published last week in PLOS One by investigators from the Cleveland Clinic, Johns Hopkins Kennedy Krieger Institute and Massachusetts General Hospital concluded that disturbance in mitochondria (energy production cells) is an underlying mechanism in a subset of individuals with autism. "There might be no difference between the inflammatory or catabolic stress of vaccinations and that of common childhood diseases" they said, and "large, population-based studies will be needed to identify a possible relationship of vaccination with autistic regression in persons with mitochondrial cytopathies."

In a November 26th response to Congresswoman Carolyn Maloney concerning adverse vaccine events, Colonel Renata Engler of the DOD Vaccine Healthcare Center commented on their collaboration with the CDC, "We have preliminary findings from one of our many on-going research studies that suggest a relationship between adverse events and multiple vaccinations exist." She added, "The recommendation for more research on subpopulation risk factors in relation to multiple vaccine combinations has been included in the Institute of Medicine (IOM) Report on Multiple Vaccines."

Regarding findings by Elliott and colleagues in August, the United Mitochondrial Disease Foundation stated that mitochondrial disorder is likely to be at the core of many health conditions including autism. These latest findings provide additional evidence that the link between autism and mitochondrial disorders is not "rare," as government officials characterized it after the Poling family was recently compensated for their daughter's vaccine injury.

SafeMinds Vice President Lyn Redwood stated, "Research clearly demonstrates that mercury in vaccines causes mitochondrial damage, yet mercury-containing vaccines continue to be administered to infants and pregnant women despite the IOM's recommendation that these populations not be exposed." SafeMinds believes the government should initiate a comprehensive study of vaccinated/unvaccinated populations examining all health outcomes, vaccine components and synergistic interactions.

Environmental mercury exposure has also been linked to mental retardation, Attention Deficit Disorder and autism. SafeMinds President Theresa Wrangham added, "Mercury in all forms is neurotoxic and is increasingly impacting public health. Congressional action is needed to shift industry from its use in medicine, utilities and consumer products."

View mercury/mitochondrial research at

SOURCE SafeMinds
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Stanford researchers find culprit in aging muscles that heal poorly
2. UCLA researchers identify markers that may predict diabetes in still-healthy people
3. Mayo Clinic researchers discover new diagnostic test for detecting infection in prosthetic joints
4. Bipolar disorder relapses halved by Melbourne researchers
5. Cell that triggers symptoms in allergy attacks can also limit damage, Stanford researchers find
6. High and mighty: first common height gene identified by researchers behind obesity gene finding
7. Researchers estimate about 9 percent of US children age 8 to 15 meet criteria for having ADHD
8. Majority of 2.4 Million U.S. Children With ADHD Not Diagnosed or Consistently Treated, According to New Gold Standard Study by Cincinnati Childrens Researchers
9. Researchers develop long-lasting growth hormone
10. Jefferson immunology researchers halt lethal rabies infection in brain
11. Purdue researchers develop technology to detect cancer by scanning surface veins
Post Your Comments:
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... health policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, ... work on several important health care topics including advance care planning, healthcare costs ...
(Date:6/25/2016)... ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due ... up a new, often overlooked aspect of head lice: the parasite’s ability to live away ... a common occurrence, but a necessary one in the event that lice have simply gotten ...
(Date:6/25/2016)... , ... June 25, 2016 , ... First Choice ... States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm ... Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has dedicated ... has implemented orthobiologic procedures as a method for treating his patients. The procedure ... doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to ...
(Date:6/25/2016)... ... ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter of ... too high can result in disappointment, perhaps even self-loathing. However, those who set the ... Research from reveals that behind the tendency to set low expectations ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016 Research and Markets has ... Companion Diagnostic Tests" report to their offering. ... Diagnostics The World Market for Companion Diagnostics ... diagnostics. Market analysis in the report includes the following: ... Vitro Diagnostic Kits) by Region (N. America, EU, ROW), 2015-2020 ...
(Date:6/23/2016)... HOUSTON , June 23, 2016  MedSource ... platform as its e-clinical software solution of choice.  ... the best possible value to their clients by ... nowEDC.  The preferred relationship establishes nowEDC as the ... pricing for MedSource,s full-service clients.  "nowEDC has long ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
Breaking Medicine Technology: